{"id":135,"date":"2019-07-16T00:02:24","date_gmt":"2019-07-16T00:02:24","guid":{"rendered":"http:\/\/clladvocates.phillipsandphillips.nz\/?page_id=135"},"modified":"2025-08-07T17:17:43","modified_gmt":"2025-08-07T04:17:43","slug":"petitions-submissions","status":"publish","type":"page","link":"https:\/\/clladvocates.nz\/?page_id=135","title":{"rendered":"Petitions &#038; submissions"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;step&#8221; row_name=&#8221;submissions&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243;][vc_custom_heading]Submissions[\/vc_custom_heading][vc_icon position=&#8221;left&#8221; icon=&#8221;fa fa-documents&#8221; icon_image=&#8221;19808&#8243; text_size=&#8221;h4&#8243; linked_title=&#8221;yes&#8221; title=&#8221;May 2025 Submission to the Health Select Committee on the Medicines Amendment Bill&#8221; link=&#8221;url:https%3A%2F%2Fclladvocates.nz%2Fwp-content%2Fuploads%2F2025%2F08%2FSubmission-to-the-Health-Select-Committee.pdf|title:Submission%20to%20the%20Health%20Select%20Committee%20on%20the%20Medicines%20Amendment%20Bill|target:_blank&#8221; uncode_shortcode_id=&#8221;200481&#8243;]<\/p>\n<div data-canvas-width=\"482.45333333333326\">This submission is made by CLL Advocates NZ, an organisation representing the interests of Chronic Lymphocytic Leukaemia (CLL) patients and their families. In New Zealand, approximately 2,800 people are diagnosed with blood cancer each year. This number encompasses leukaemia, lymphoma and myeloma.\u00a0 Leukaemia accounts for around 700 cases annually \u2014 the majority of these being CLL.<\/div>\n<p>[\/vc_icon][vc_icon position=&#8221;left&#8221; icon=&#8221;fa fa-documents&#8221; size=&#8221;fa-2x&#8221; text_size=&#8221;h4&#8243; linked_title=&#8221;yes&#8221; title=&#8221;7 August 2019&#8243; link=&#8221;url:https%3A%2F%2Fclladvocates.nz%2F%3Fp%3D427|title:Dr%20Neil%20Graham%E2%80%99s%20talk%20%E2%80%93%20presented%20to%20the%20Health%20Select%20Committee|target:_blank&#8221; link_text=&#8221;View the speech&#8221; uncode_shortcode_id=&#8221;161642&#8243;]Dr Neil Graham presented to the Health Select Committee on 7 August 2019 to support the submission calling for the Select Committee to strongly recommend funding of two life-saving treatments.[\/vc_icon][vc_icon position=&#8221;left&#8221; icon=&#8221;fa fa-documents&#8221; size=&#8221;fa-2x&#8221; text_size=&#8221;h4&#8243; linked_title=&#8221;yes&#8221; title=&#8221;10 June 2019&#8243; link=&#8221;url:https%3A%2F%2Fclladvocates.nz%2Fwp-content%2Fuploads%2F2019%2F07%2F19-June-2019-Neil-Graham-CLL-Submission-to-Health-Select-Committee.pdf|target:_blank&#8221; link_text=&#8221;View the submission&#8221; uncode_shortcode_id=&#8221;513096&#8243;]Submission to the Health Select Committee on the funding on life saving medicines ibrutinib and venetoclax for Chronic Lymphocytic Leukaemia (CLL).[\/vc_icon][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;step&#8221; row_name=&#8221;submissions&#8221;][vc_column column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":128,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-135","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/pages\/135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=135"}],"version-history":[{"count":20,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/pages\/135\/revisions"}],"predecessor-version":[{"id":22505,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/pages\/135\/revisions\/22505"}],"up":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/pages\/128"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}